DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2023 Jul 5

PMID 37405760

Authors

Masaaki Yoshida

Taiki Kokubun

Kota Sato

Satoru Tsuda

Yu Yokoyama

Noriko Himori

Toru Nakazawa

Affiliations

Soon will be listed here.

Abstract

Purpose: This study investigated the effect of dipeptidyl peptidase-4 inhibitors (DPP-4is) on fibrosis after glaucoma filtering surgery with clinical data and an in vitro model that used transforming growth factor-β (TGF-β) to induce human Tenon's fibroblast (HTF) fibrosis.

Methods: The medical records of 41 eyes of 35 patients with diabetes with neovascular glaucoma (NVG) who received initial trabeculectomy were retrospectively reviewed. The surgical success rate was compared between cases that received (n = 23) and did not receive (n = 18) DPP-4i treatment for diabetes. The antifibrotic effects of linagliptin (a DPP-4i) were evaluated with quantitative real-time PCR for fibrosis markers (α-smooth muscle actin, collagen Iα, and fibronectin), a scratch assay, and a collagen gel contraction assay of primary cultured HTFs treated with TGF-β1 and linagliptin. Western blotting analysis was performed to evaluate the levels of phosphorylated Smad2 and Smad3 in the presence of linagliptin.

Results: The Kaplan-Meier curve for bleb survival was higher in patients who received DPP-4is (P = 0.017, log-rank test). The in vitro experiments demonstrated that treatment with linagliptin attenuated the elevated levels of fibrosis markers induced by TGF-β1 in HTFs. Linagliptin treatment also prevented the migration and gel contraction of HTFs. Linagliptin inhibited the phosphorylation of Smad2 and Smad3, which is the canonical pathway of TGF-β signaling.

Conclusions: The current study indicates the potential effect of DPP-4is for maintaining bleb function after glaucoma filtering surgery in patients with diabetes with NVG. Our results demonstrate that linagliptin attenuates fibrotic change in HTFs by inhibiting TGF-β/Smad signaling.

Citing Articles

Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy.

Sacchi M, Tomaselli D, Ruggeri M, Aiello F, Sabella P, Dore S Int J Mol Sci. 2025; 26(5).

PMID: 40076946 PMC: 11900438. DOI: 10.3390/ijms26052327.

New Insights into the Pleiotropic Actions of Dipeptidyl Peptidase-4 Inhibitors Beyond Glycaemic Control.

Mangoura S, Ahmed M, Zaka A touchREV Endocrinol. 2024; 20(2):19-29.

PMID: 39526061 PMC: 11548370. DOI: 10.17925/EE.2024.20.2.5.

Development and Verification of a Novel Three-Dimensional Aqueous Outflow Model for High-Throughput Drug Screening.

Fung M, Armstrong J, Zhang R, Vinokurtseva A, Liu H, Hutnik C Bioengineering (Basel). 2024; 11(2).

PMID: 38391628 PMC: 10885921. DOI: 10.3390/bioengineering11020142.

References

Kiddee W, Orapiriyakul L, Kittigoonpaisan K, Tantisarasart T, Wangsupadilok B . Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial. J Glaucoma. 2014; 24(8):600-6. PMC: 4614532. DOI: 10.1097/IJG.0000000000000194. View

Hirakawa H, Zempo H, Ogawa M, Watanabe R, Suzuki J, Akazawa H . A DPP-4 inhibitor suppresses fibrosis and inflammation on experimental autoimmune myocarditis in mice. PLoS One. 2015; 10(3):e0119360. PMC: 4359137. DOI: 10.1371/journal.pone.0119360. View

Kokubun T, Yamamoto K, Sato K, Akaishi T, Shimazaki A, Nakamura M . The effectiveness of colchicine combined with mitomycin C to prolong bleb function in trabeculectomy in rabbits. PLoS One. 2019; 14(3):e0213811. PMC: 6424470. DOI: 10.1371/journal.pone.0213811. View

Futakuchi A, Inoue T, Wei F, Inoue-Mochita M, Fujimoto T, Tomizawa K . YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis. Invest Ophthalmol Vis Sci. 2018; 59(7):3069-3078. DOI: 10.1167/iovs.18-24258. View

Fannin L, Schiffman J, Budenz D . Risk factors for hypotony maculopathy. Ophthalmology. 2003; 110(6):1185-91. DOI: 10.1016/S0161-6420(03)00227-6. View

Kokubun T, Tsuda S, Kunikata H, Yasuda M, Himori N, Kunimatsu-Sanuki S . Characteristic Profiles of Inflammatory Cytokines in the Aqueous Humor of Glaucomatous Eyes. Ocul Immunol Inflamm. 2017; 26(8):1177-1188. DOI: 10.1080/09273948.2017.1327605. View

Chen K, Wu C, Roy S, Lee S, Liu J . Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci. 1999; 40(11):2627-32. View

Tomasek J, Gabbiani G, Hinz B, Chaponnier C, Brown R . Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3(5):349-63. DOI: 10.1038/nrm809. View

Kawana K, Kiuchi T, Yasuno Y, Oshika T . Evaluation of trabeculectomy blebs using 3-dimensional cornea and anterior segment optical coherence tomography. Ophthalmology. 2009; 116(5):848-55. DOI: 10.1016/j.ophtha.2008.11.019. View

10.

Song S, Yu X, Zhang P, Dai H . Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy. J Diabetes Complications. 2020; 34(9):107641. DOI: 10.1016/j.jdiacomp.2020.107641. View

11.

Futakuchi A, Inoue T, Fujimoto T, Kuroda U, Inoue-Mochita M, Takahashi E . Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA). Invest Ophthalmol Vis Sci. 2017; 58(4):2421-2429. DOI: 10.1167/iovs.16-21403. View

12.

Florentin M, Kostapanos M, Papazafiropoulou A . Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment. World J Diabetes. 2022; 13(2):85-96. PMC: 8855136. DOI: 10.4239/wjd.v13.i2.85. View

13.

Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y . Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes. 2014; 63(6):2120-31. DOI: 10.2337/db13-1029. View

14.

Cabourne E, Clarke J, Schlottmann P, Evans J . Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2015; (11):CD006259. PMC: 8763343. DOI: 10.1002/14651858.CD006259.pub2. View

15.

Sato K, Nishiguchi K, Maruyama K, Moritoh S, Fujita K, Ikuta Y . Topical ocular dexamethasone decreases intraocular pressure and body weight in rats. J Negat Results Biomed. 2016; 15:5. PMC: 4789283. DOI: 10.1186/s12952-016-0048-x. View

16.

Igarashi N, Honjo M, Aihara M . Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy. Exp Eye Res. 2020; 203:108421. DOI: 10.1016/j.exer.2020.108421. View

17.

Jampel H, Pasquale L, DiBernardo C . Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol. 1992; 110(8):1049-50. DOI: 10.1001/archopht.1992.01080200029011. View

18.

Kokubun T, Tsuda S, Kunikata H, Himori N, Yokoyama Y, Omodaka K . Prediction of Surgical Outcome After Trabeculectomy for Neovascular Glaucoma With Anterior-segment Optical Coherence Tomography. J Glaucoma. 2018; 27(12):1157-1164. DOI: 10.1097/IJG.0000000000001081. View

19.

Grover D, Kornmann H, Fellman R . Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. J Glaucoma. 2020; 29(3):226-235. DOI: 10.1097/IJG.0000000000001438. View

20.

Yamamoto T, Kuwayama Y . Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study. Ophthalmology. 2010; 118(3):453-8. DOI: 10.1016/j.ophtha.2010.07.002. View